
Publication
United States Corporate Transparency Act off again
The US Corporate Transparency Act (CTA) is a law that requires companies to disclose information on their beneficial owners.
Global | Publication | November 2015
Norton Rose Fulbright’s global blockchain and cryptocurrency team has produced a global legal and regulatory guide to cryptocurrencies.
The guide is issued in a series of chapters, published monthly.
To date, most litigation involving cryptocurrency has related to breach of contract and fraud (the Butterfly Labs case) or insolvency (Mt Gox). However, as cryptocurrencies become more widely used it is reasonable to expect that the litigation risk surrounding them will also increase.
A common narrative in the cryptocurrency space is that the public ledger and cryptocurrency units are somehow beyond the reach of the state and the courts. This is partly because, from a practical point of view, decentralised peer-to-peer networks are governed and operated on the principle of distributed consensus and are designed to frustrate the possibility of third-party interference – including that of the courts. This narrative is misleading. In many cases, courts will be able to exert control over individuals in their jurisdiction to compel the disclosure of private keys and thereby access cryptocurrency. That process is a common thread which we will explore in this chapter.
In this chapter we will consider:
If you would like to discuss any aspect of this topic further, please get in touch.
Publication
The US Corporate Transparency Act (CTA) is a law that requires companies to disclose information on their beneficial owners.
Publication
Health Canada has published a Notice of Intent to publish a ministerial order to exempt natural health products (NHPs) licensed between June 21, 2025, and June 21, 2028, from labelling requirements that are set to come into force this summer under the Natural Health Products Regulations (NHPR).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025